Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Having an undetectable viral load did not change the risk, which nevertheless was not as severe as the risk tied to diabetes.
Large trial of HIV vaccine finds it does not prevent HIV
Research indicates that there are numerous differences in how HIV behaves in women versus men.
“You must be closed up because you HIV people like making babies, and it just annoys us.”
In theory, starting antiretrovirals quiets the immune system, leading more immune cells to become part of the inactive reservoir.
Conducted in South Africa, it’s one of three major late-stage trials.
A South African study found that treating the virus within 48 hours or waiting up to two weeks led to comparable viral suppression rates.
A pair of studies focused on KwaZulu-Natal, South Africa.
A long-term study found that kidney transplants between people with HIV have high success rates.
Only HIV vax to show any efficacy prompted strong immune response in new study
This finding suggests that the HIV-preventing vaginal ring that awaits regulatory approval may achieve widespread use.
People with HIV make their own artistic statement in the photo-storytelling project “Through Positive Eyes.”
The rollout of antiretroviral treatment in this hard-hit region has apparently not lowered this group’s risk of acquiring HIV.
A long-term study also found that superinfection—acquiring a second strain of HIV—was not a risk for the transplantees.
Peace Corps Response volunteer Brian Sway’s work just earned him a prestigious award.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.